Caroline Ong1,2, Minghao Liu3,4, Sadiya Thermidor5,3, Marwen Eid5,3, Eugenia Gianos5,3. 1. Division of Cardiology, Northwell Health, Lenox Hill Hospital, New York, NY, USA. cong1@northwell.edu. 2. Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. cong1@northwell.edu. 3. Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. 4. Department of Endocrinology, Northwell Health, Lenox Hill Hospital, New York, NY, USA. 5. Division of Cardiology, Northwell Health, Lenox Hill Hospital, New York, NY, USA.
Abstract
PURPOSE OF REVIEW: Transgender individuals represent a growing part of our population with current trends indicating that clinicians will be treating more transgender patients in both the inpatient and outpatient setting. Current cardiovascular guidelines lack recommendations for transgender care secondary to limited data in this population. As we await future guideline recommendations, we provide a comprehensive review of the literature and practical management strategies related to transgender cardiovascular health. RECENT FINDINGS: Transgender individuals are at higher risk for some cardiovascular diseases compared to their cisgender counterparts. Gender-affirming hormone therapy, concomitant health conditions, lifestyle habits, access to services, and quality of care all contribute to this finding. While it is likely both safe and appropriate to apply current CVD guidelines to the care of transgender men and women, clinicians should consider additional factors in risk assessment and address unique aspects of care at every visit.
PURPOSE OF REVIEW: Transgender individuals represent a growing part of our population with current trends indicating that clinicians will be treating more transgender patients in both the inpatient and outpatient setting. Current cardiovascular guidelines lack recommendations for transgender care secondary to limited data in this population. As we await future guideline recommendations, we provide a comprehensive review of the literature and practical management strategies related to transgender cardiovascular health. RECENT FINDINGS: Transgender individuals are at higher risk for some cardiovascular diseases compared to their cisgender counterparts. Gender-affirming hormone therapy, concomitant health conditions, lifestyle habits, access to services, and quality of care all contribute to this finding. While it is likely both safe and appropriate to apply current CVD guidelines to the care of transgender men and women, clinicians should consider additional factors in risk assessment and address unique aspects of care at every visit.
Authors: Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen Journal: J Clin Endocrinol Metab Date: 2017-11-01 Impact factor: 5.958
Authors: Henk Asscheman; Erik J Giltay; Jos A J Megens; W Pim de Ronde; Michael A A van Trotsenburg; Louis J G Gooren Journal: Eur J Endocrinol Date: 2011-01-25 Impact factor: 6.664
Authors: E Kale Edmiston; Cameron A Donald; Alice Rose Sattler; J Klint Peebles; Jesse M Ehrenfeld; Kristen Laurel Eckstrand Journal: Transgend Health Date: 2016-11-01
Authors: Logan S Casey; Sari L Reisner; Mary G Findling; Robert J Blendon; John M Benson; Justin M Sayde; Carolyn Miller Journal: Health Serv Res Date: 2019-10-28 Impact factor: 3.402